Marshall Wace, LLP Avid Bioservices, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 195,461 shares of CDMO stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
195,461Holding current value
$2.22 Million% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding CDMO
# of Institutions
181Shares Held
65MCall Options Held
21.3KPut Options Held
110K-
Black Rock Inc. New York, NY5.11MShares$57.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.1MShares$57.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$43.1 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY3.65MShares$41.3 Million2.71% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.4MShares$38.5 Million2.78% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $705M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...